Valuation: PLC Systems Inc.

Market Cap 4.56M 4M 3.78M 3.44M 6.44M 437M 6.49M 45.2M 17.51M 223M 17.11M 16.74M 717M P/E 2020
-0.28x
P/E 2021 -0.43x
Enterprise Value -8.93M -7.83M -7.4M -6.74M -12.62M -856M -12.71M -88.55M -34.3M -437M -33.52M -32.8M -1.41B EV / Sales 2020
1.77x
EV / Sales 2021 -0.22x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
Manager TitleAgeSince
Director of Finance/CFO 62 2014-06-30
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+3.62%+46.99%+33.49% 251B
+0.32%+5.99%+23.71%-10.93% 157B
+1.42%+3.01%-7.52%+38.17% 141B
-1.70%+1.34%-55.25%-18.36% 64.75B
+0.65%-2.23%+14.64%+24.23% 49.41B
+1.56%+0.05%-15.70%-20.02% 47.09B
-0.03%+10.43%+41.76%+54.36% 48.73B
+0.75%+2.82%+50.64%+60.00% 42.28B
-1.42%+12.68%+192.87%+105.46% 41.36B
Average +0.12%+4.22%+32.46%+29.60% 93.66B
Weighted average by Cap. +0.11%+4.19%+27.30%+24.54%

Financials

2020 2021
Net sales 5.48M 4.81M 4.54M 4.14M 7.75M 525M 7.8M 54.34M 21.05M 268M 20.57M 20.13M 862M 6.43M 5.64M 5.33M 4.85M 9.09M 616M 9.15M 63.73M 24.68M 315M 24.13M 23.61M 1.01B
Net income -21.92M -19.23M -18.16M -16.55M -30.98M -2.1B -31.2M -217M -84.18M -1.07B -82.28M -80.5M -3.45B -22.03M -19.33M -18.26M -16.64M -31.14M -2.11B -31.36M -218M -84.61M -1.08B -82.7M -80.91M -3.47B
Net Debt -530K -465K -439K -400K -749K -50.8M -755K -5.26M -2.04M -25.95M -1.99M -1.95M -83.41M -13.49M -11.83M -11.18M -10.19M -19.07M -1.29B -19.2M -134M -51.8M -660M -50.63M -49.54M -2.12B
Logo PLC Systems Inc.
Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Company’s wholly owned subsidiaries include Viveve, Inc. and Viveve BV.
Employees
-